Back

Results - Announcements

Sales rise 7.90% to Rs 2754.07 crore

Piramal Pharma consolidated net profit rises 51.58% in the March 2025 quarter

15-May-2025, 07:42
Net profit of Piramal Pharma rose 51.58% to Rs 153.50 crore in the quarter ended March 2025 as against Rs 101.27 crore during the previous quarter ended March 2024. Sales rose 7.90% to Rs 2754.07 crore in the quarter ended March 2025 as against Rs 2552.36 crore during the previous quarter ended March 2024.

For the full year,net profit rose 411.39% to Rs 91.13 crore in the year ended March 2025 as against Rs 17.82 crore during the previous year ended March 2024. Sales rose 11.99% to Rs 9151.18 crore in the year ended March 2025 as against Rs 8171.16 crore during the previous year ended March 2024.

Particulars	Quarter Ended			Year Ended
	Mar. 2025	Mar. 2024	% Var.	Mar. 2025	Mar. 2024	% Var.
Sales	2754.07	2552.36	8	9151.18	8171.16	12
OPM %	20.37	20.76	-	15.79	14.64	-
PBDT	515.56	454.13	14	1230.98	982.65	25
PBT	272.80	258.00	6	414.64	242.08	71
NP	153.50	101.27	52	91.13	17.82	411